DIAGNOSIS, TREATMENT AND OUTCOME OF LUNG CANCER PATIENTS
NCT05254119 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000
Last updated 2024-04-04
Summary
Observational, prospective clinical research, multi-center clinical research platform with the main objective to assess molecular biomarker testing, treatment and outcome of patients with NSCLC or SCLC in Turkey
Conditions
- Non Small Cell Lung Cancer
- Small-cell Lung Cancer
Sponsors & Collaborators
-
Mahmut Gumus
lead NETWORK
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-01
- Primary Completion
- 2024-12-31
- Completion
- 2025-02-28
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Oral Microbiome Diagnostics of Lung Cancer
NCT06270992 ·Status: RECRUITING
-
Pulmonary and Extrapulmonary Impairments in Patients With Lung Cancer Awaiting Surgery
NCT04450719 ·Status: COMPLETED
-
Studies Examining the Importance of Smoking After Being Diagnosed With Lung Cancer
NCT01192256 ·Status: COMPLETED
-
Biomarker Discovery in Lung Cancer - Malaysia
NCT06504927 ·Status: RECRUITING
-
Lung Cancer Registry for Lung Cancer Patients
NCT03276429 ·Status: COMPLETED
-
Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America
NCT04227457 ·Status: COMPLETED
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Comparison of Circulating Tumor DNA and Tumor Tissue DNA by Targeted Sequencing in Non-Small Cell Lung Cancer
NCT02645318 ·Status: COMPLETED
-
Metabolic and Microbial Profiling of Lung Cancer
NCT03998189 ·Status: TERMINATED ·Phase: NA
-
Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer Patients
NCT03881046 ·Status: COMPLETED
-
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529 ·Status: RECRUITING
-
Survival Outcomes of Lung Cancer
NCT03647098 ·Status: RECRUITING
-
Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
NCT06699979 ·Status: RECRUITING
-
DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma
NCT06477211 ·Status: COMPLETED
-
Prospective Observational Study on ES-SCLC
NCT07173946 ·Status: NOT_YET_RECRUITING
-
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
NCT04712877 ·Status: RECRUITING
-
Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer
NCT05372081 ·Status: UNKNOWN
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
NCT01052818 ·Status: UNKNOWN
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
Prognostic Value of Body Composition in Lung Cancer
NCT05512429 ·Status: COMPLETED
-
Impact of Risk for OSA in Lung Cancer
NCT04003961 ·Status: COMPLETED
-
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
NCT03710616 ·Status: UNKNOWN
-
Immune-Marker Platform for Patients With Advanced Lung Cancer
NCT07150598 ·Status: NOT_YET_RECRUITING